Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 3
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vytrus Biotech SL (VYT)
"Vytrus Biotech SL stock price live, this page displays BME VYT stock exchange data. View the VYT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vytrus Biotech SL real time stock price chart below.
What Is the Vytrus Biotech SL Stock Price Today?
The Vytrus Biotech SL stock price today is 2.40.
What Is the Stock Symbol for Vytrus Biotech SL?
The stock symbol for Vytrus Biotech SL is ""VYT.""
What Stock Exchange Does Vytrus Biotech SL Trade On?
Vytrus Biotech SL is listed and trades on the Madrid stock exchange.
Is Vytrus Biotech SL a Good Stock to Buy?
Determining whether Vytrus Biotech SL—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VYT quote. (ISIN: ES0105618005)"
What Is the Vytrus Biotech SL Stock Price Today?
The Vytrus Biotech SL stock price today is 2.40.
What Is the Stock Symbol for Vytrus Biotech SL?
The stock symbol for Vytrus Biotech SL is ""VYT.""
What Stock Exchange Does Vytrus Biotech SL Trade On?
Vytrus Biotech SL is listed and trades on the Madrid stock exchange.
Is Vytrus Biotech SL a Good Stock to Buy?
Determining whether Vytrus Biotech SL—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VYT quote. (ISIN: ES0105618005)"
Madrid
Currency in EUR
2.40
+0.04(+1.69%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.40
2.40
52 wk Range
1.86
2.60
VYT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.402.40
52 wk Range
1.862.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
VYT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
3.28
Upside
+36.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 3
Vytrus Biotech SL Company Profile
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. It offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a microbiota photoprotector; Olea Vitae cellular oil for ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a biological deodorant; and Sarcoslim Re-Shape to reduce fat on tissue. The company also offers Capilia Longa for hair growth reactivation; Luminia Granatum for skin brightening;Elaya Renova a hair tensegrist; Kannabia Sense that stimulates the microbiota-skin-brain axis; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton for protection against photo-ageing. It sells its products to approximately 560 countries. Vytrus Biotech, S.A. was incorporated in 2009 and is based in Barcelona, Spain.
Compare VYT to Peers and Sector
Metrics to compare | VYT | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipVYTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.5x | 4.4x | 11.6x | |
PEG Ratio | −94.28 | 0.01 | 0.03 | |
Price/Book | 2.6x | 1.5x | 1.5x | |
Price / LTM Sales | 3.4x | 0.7x | 0.9x | |
Upside (Analyst Target) | 39.0% | 47.3% | 23.2% | |
Fair Value Upside | Unlock | 15.3% | 10.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.28
(+36.67% Upside)
Earnings
Latest Release
Mar 28, 2023
EPS / Forecast
0.04 / --
Revenue / Forecast
1.64M / --
People Also Watch
FAQ
What Is the Vytrus Biotech (VYT) Stock Price Today?
The Vytrus Biotech stock price today is 2.40
What Stock Exchange Does Vytrus Biotech Trade On?
Vytrus Biotech is listed and trades on the Madrid stock exchange.
What Is the Stock Symbol for Vytrus Biotech?
The stock symbol for Vytrus Biotech is "VYT."
What Is the Vytrus Biotech Market Cap?
As of today, Vytrus Biotech market cap is 17.80M.
What is Vytrus Biotech Earnings Per Share?
The Vytrus Biotech EPS is 0.092.
From a Technical Analysis Perspective, Is VYT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.